T. Rowe Price Associates’s Carisma Therapeutics CARM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
2022
Q1
$129K Sell
2021
Q4
$219K Buy
2021
Q3
$44K Hold
2021
Q2
$259K Sell
2021
Q1
$325K Buy
2017
Q4
Sell
2017
Q3
$83K Hold
2017
Q2
$83K Buy
2017
Q1
$62K Hold
2016
Q4
$54K Hold
2016
Q3
$79K Buy